NovaBay Pharmaceuticals to Present at Rodman and Renshaw Annual Global Investment Conference

EMERYVILLE, Calif., Sept. 7, 2010 GLOBE NEWSWIRE — NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing its proprietary and patented Aganocide compounds NYSE Amex:NBY, announces that Thomas Paulson, CFO, will present at the Rodman & Renshaw Annual Global Investment Conference. The presentation is currently scheduled for 12:05 PM, September 14, 2010, in [...] http://bit.ly/blAYRM